Mariel focuses on exploring new investment themes and incubating new companies that could potentially become Series A investments.

Prior to joining Santé, Mariel was a Biodesign Innovation Fellow at Stanford University, where she identified and defined unmet healthcare needs, invented novel technologies to address them, and charted paths to their implementation. Before joining Biodesign, Mariel held several new product development roles at Stryker Neurovascular, a medical device company where she ideated, developed and launched therapies for hemorrhagic and ischemic stroke patients.

Mariel earned her BS in biomedical engineering with honors from the University of Texas at Austin.